¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦38Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦38Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : °æÁÖÈ­¹éÄÁº¥¼Ç¼¾ÅÍ(HICO) 3Ãþ 300B ¿Ü 2°³·ë

±³À°ÁÖÁ¦ : 2023 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦38Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÁöÀºÁ¤
¿¬¶ôó : 02-512-5915  

À̸ÞÀÏ : gyncancer@gyncancer.or.kr

±³À°Á¾·ù : »êºÎÀΰú

Âü¼®¿¹»óÀÎ : 3000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 270,000¿ø  

ºñ°í ºÎÀÎ¾Ï Àü¹®ÀÇ 20¸¸¿ø / ÀüÀÓÀÇ ¹× ŸºÐ°ú Àü¹®ÀÇ 12¸¸¿ø / Àü°øÀÇ ¹× °£È£»ç, ¿¬±¸¿ø 10¸¸¿ø (¸¸Âù 2¸¸¿ø Ãß°¡ / JGO Workshop 5¸¸¿ø Ãß°¡)

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 08:30~09:00 È¿À²ÀûÀÎ ³í¹® ÀÛ¼º °úÁ¤ÀÇ ÀÌÇØ ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 09:00~09:30 Reviewer°¡ ¸»ÇÏ´Â ³í¹®ÀÛ¼º¹ý (Revision ÈÄ¿¡µµ Reject µÇ´Â ÀÌÀ¯) À̼±¿µ(°Ç±¹ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 09:30~09:50 ³í¹® ÀÛ¼º½Ã ÀúÀÚ Âü¿©ÀÇ Á߿伺 ±è¼¼ÀÍ(¼­¿ïÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 09:50~10:00 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ 300B 10:00~10:30 Coffee Break ( )

Åä·Ð 04¿ù 29ÀÏ 300B 10:30~11:00 ÆÀº° reviewer comment ¸¸µé±â ¹Î°æÁø/¹ÚÁ¤¿­/À̼ºÁ¾/ÀÌÀ¯¿µ/ÀÌÁ¤À±(°í·ÁÀÇ´ë/¿ï»êÀÇ´ë/°¡Å縯ÀÇ´ë/¼º±Õ°üÀÇ´ë/¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 10:40~10:50 Tumor-infiltrating regulatory T cells determine response of immune checkpoint blockade in ovarian clear cell carcinoma ¹ÚÁؽÄ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 10:50~11:00 Prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer ÇãÁøÈ£(±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø)

Åä·Ð 04¿ù 29ÀÏ 300B 11:00~12:00 ÆÀº° ¹ßÇ¥ ¹× Åä·Ð (ÆÀº° 11¡¯) ( )

Åä·Ð 04¿ù 29ÀÏ 300C 11:00~11:10 Distillate discussion Á¶ÇѺ°(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300C 11:10~11:20 Floor discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 11:20~11:30 Risk of ovarian cancer according to hormone replacement therapy in postmenopausal women with history of endometriosis or de-novo endometriosis À̹æÇö(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 11:30~11:40 Final primary analysis in the original cohort of KGOG3046/TRU-D: a phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer ÀÌ´ÙÇý(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300C 11:40~11:50 Distillate discussion ¾î°æÁø(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300C 11:50~12:00 Floor discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ 300B 12:00~12:10 Award & Closing ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B+300C 12:10~12:25 Various types of hemostatic agents in gynecologic surgical procedure: what can we choose? ÀÌÀºÁö(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300B+300C 12:25~12:40 The only once-daily PARPi monotherapy for first-line platinum responders with BRCAm, HRd or HRp OC ¹Î°æÁø(°í·ÁÀÇ´ë)

½Ä»ç 04¿ù 29ÀÏ 300B+300C 12:40~13:20 Lunch ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 13:30~14:10 PANDEMOMICS: Challenging Assumptions in Gynecologic Oncology Michael A. Bookman(Kaiser Permanente Northern California)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 13:30~13:50 PANDEMOMICS: Challenging Assumptions in Gynecologic Oncology ¹ÚÁ¤¿­(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300C 13:50~14:00 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 14:00~14:25 Ovarian cancer À̹æÇö(ÀÎÇÏÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 14:10~14:20 Distillate discussion ÃÖ¹Îö(Â÷ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 14:20~14:27 Laparoscopic staging with articulating instruments in early endometrial cancer ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 14:25~14:53 Cervical cancer À̼ºÁ¾(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 14:27~14:30 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 14:30~14:37 Laparoscopic staging and sentinel lymph node with articulating instruments in early endometrial cancer ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 14:37~14:40 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 14:40~14:47 Fluorescent-image-guided pelvic lymph node dissection with radical hysterectomy in single-port laparoscopy ÀÌ¿µÁÖ(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 14:47~14:50 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 14:50~14:57 Single port assisted laparoscopic debulking surgery for endometrial cancer with bulky lymph node lesion ÀÌ¿µÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 14:53~15:03 Early detection of cervical cancer ¹èÀ縸(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 14:57~15:00 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 15:00~15:07 Robotic-assisted radical vaginal trachelectomy (fertility preservation) Amal Alsomairi(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ 300C 15:03~15:20 Corpus cancer ±èÁÖÇö(¿ï»êÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 15:07~15:10 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 15:10~15:17 Laparoscopic left common iliac vein injury & repair Amal Alsomairi(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 15:17~15:20 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ 300B/300C 15:20~15:40 break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 15:40~15:47 The identifying renal artery variant during retroperitoneal laparoscopic para-aortic lymphadenectomy Á¶¼º½Ç(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300C 15:40~16:50 Resident Survival Quiz ³ëÁØÈ£(¼º±Õ°üÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 15:47~15:50 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 15:50~15:57 Laparoscopic optimal restaging surgery for women with epithelial ovarian cancer underwent HIFU management Á¶¼º½Ç(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 15:57~16:00 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 16:00~16:07 Laparoscopic complete resection of bulky para-aortic lymph node metastasis Á¦°¥º¸½½(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 16:07~16:10 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 16:10~16:17 Laparoscopic resection of a huge metastatic para-aortic lymph node located between the inferior mesenteric artery and left renal vein Á¦°¥º¸½½(ÇѾçÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 16:17~16:20 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 16:20~16:27 Robot assisted laparoscopic staging surgery in early stage of ovarian cancer ¾ÈÁ¤È¯(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 16:27~16:30 Discussion ( )

±³À°½Ã°£ 04¿ù 29ÀÏ 300B 16:30~16:37 Simultaneously Extraperitoneal and Transperitoneal Staging Surgery of Endometrial Cancer ¾ÈÁ¤È¯(¿¬¼¼ÀÇ´ë)

Åä·Ð 04¿ù 29ÀÏ 300B 16:37~16:40 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ 300B/300C 17:00~17:10 Closing Remark & Surgical Film Award ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Á¦38Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³¾È¾Ïº´¿ø (¿Â¶óÀÎ) 2023³â »ó¹Ý±â °³¿øÀÇ ¿¬¼ö±³À° : 2023-04-29
´ÙÀ½±Û 2023³â ¼øõ¸¸ ¼ÒÈ­±â³»½Ã°æ ¼¼¹Ì³ª(Add-on options for treatment of GERD, °úÇü¼º ¿ëÁ¾) : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 49 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 36 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 38 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 48 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 39 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 32 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 13 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 13 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 30 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 15 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 13 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 34 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 24 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 30 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 23 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷